Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 2, 2023
MIRD Pamphlet No. 28, Part 1: MIRDcalc-A Software Tool for Medical Internal Radiation Dosimetry
Adam L Kesner, Lukas M Carter, Juan C Ocampo Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2007
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma
Ajay K Gopal, Joseph G Rajendran, Ted A Gooley, et al.
Cancer Research
|
January 2, 2009
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia
John M Pagel, Dana C Matthews, Aimee Kenoyer, et al.
Cancer Research
|
September 28, 2014
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model
Ethan R Balkin, Aimee Kenoyer, Johnnie J Orozco, et al.
Cancer Research
|
February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211
Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.
Molecular Cancer Therapeutics
|
July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell Lymphomas
Johnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies
Eneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Blood
|
June 12, 2009
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
Damian J Green, John M Pagel, Eneida R Nemecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 17, 2013
MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications
Yuni K Dewaraja, Michael Ljungberg, Alan J Green, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 2, 2023
MIRD Pamphlet No. 28, Part 1: MIRDcalc-A Software Tool for Medical Internal Radiation Dosimetry
Adam L Kesner, Lukas M Carter, Juan C Ocampo Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2007
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma
Ajay K Gopal, Joseph G Rajendran, Ted A Gooley, et al.
Cancer Research
|
January 2, 2009
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia
John M Pagel, Dana C Matthews, Aimee Kenoyer, et al.
Cancer Research
|
September 28, 2014
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model
Ethan R Balkin, Aimee Kenoyer, Johnnie J Orozco, et al.
Cancer Research
|
February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211
Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.
Molecular Cancer Therapeutics
|
July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell Lymphomas
Johnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies
Eneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Blood
|
June 12, 2009
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
Damian J Green, John M Pagel, Eneida R Nemecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 17, 2013
MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications
Yuni K Dewaraja, Michael Ljungberg, Alan J Green, et al.
Page
of 9